Bob Yedid | Investor Relations, LifeSci Advisors |
Ronald Andrews | President and Chief Executive Officer |
Mitch Levine | Chief Financial Officer |
Padma Sundar | Senior Vice President of Marketing & Market Access |
Doug Ross | Chief Medical Officer |
Lyndal Hesterberg | Chief Scientific Officer |
Paul Knight | Janney Capital Markets |
Bruce Jackson | The Benchmark Company |
Keay Nakae | Chardan Capital Markets |
Rachel Vatnsdal | Piper Sandler |
Thomas Flaten | Lake Street Capital Markets |
Greetings and welcome to the OncoCyte Corporation Fourth Quarter and Fiscal Year 2019 Earnings Conference Call. At this time, all participants are in a listen-only mode and a brief question-and-answer session will follow the formal presentation. [Operator Instructions].
As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Bob Yedid, Managing Director at LifeSci Advisors.